Endocrine responses after d-fenfluramine and ipsapirone challenge:: Further support for Cloninger's tridimensional model of personality

被引:26
作者
Hennig, J [1 ]
Toll, C [1 ]
Schonlau, P [1 ]
Rohrmann, S [1 ]
Netter, P [1 ]
机构
[1] Univ Giessen, Dept Psychol, Ctr Psychobiol & Behav Med, D-35394 Giessen, Germany
关键词
d-fenfluramine; ipsapirone; cortisol; prolactin; personality;
D O I
10.1159/000026631
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, th is study investigates whether subjects characterized by blunted cortisol (CORT) responses after ipsapirone (PS) relate to different subfactors of HA from those characterized by blunted prolactin (PRL) responses after treatment with d-fenfluramine (D-FEN). Moreover, subjects blunted in both responses should differ in scale values of subfactors of HA from those with only one or no blunted reactions. In the first part of the experiment, 16 healthy male volunteers were treated with 15 mg D-FEN. The second part of the study (about 1 year later) consists of a challenge with the partial 5-hydroxytryptamine-1a (5-HT1a) agonist IFS (10 mg) in the same subjects. The results indicate that blunted PRL responses are accompanied by high values in HA, while the main effect of IFS responsivity did not relate significantly to this dimension. With respect to the subscales of HA, subjects blunted in both responses (PRL-/C-) exhibit significantly higher levels in fatigability and asthenia when compared to all other groups (PRL-/C+, PRL+/C-, PRL+/C+). The data demonstrate that, combined challenge tests may shed more light on the biological basis of personality and that HA and most clearly fatigability and asthenia relate to the 5-HT system. Copyright (C) 2000 S. KargerAG. Basel.
引用
收藏
页码:38 / 47
页数:10
相关论文
共 79 条
  • [1] SEROTONIN IN HUMAN LUMBAR CEREBROSPINAL-FLUID - A REASSESSMENT
    ANDERSON, GM
    MEFFORD, IN
    TOLLIVER, TJ
    RIDDLE, MA
    OCAME, DM
    LECKMAN, JF
    COHEN, DJ
    [J]. LIFE SCIENCES, 1990, 46 (04) : 247 - 255
  • [2] Acute stress markers in humans: Response of plasma glucose, cortisol and prolactin to two examinations differing in the anxiety they provoke
    Armario, A
    Marti, O
    Molina, T
    dePablo, J
    Valdes, M
    [J]. PSYCHONEUROENDOCRINOLOGY, 1996, 21 (01) : 17 - 24
  • [3] NEUROENDOCRINE RESPONSES IN PSYCHIATRIC AND PAIN PATIENTS WITH MAJOR DEPRESSION
    ATKINSON, JH
    KREMER, EF
    RISCH, SC
    DANA, R
    JANOWSKY, DS
    [J]. BIOLOGICAL PSYCHIATRY, 1986, 21 (07) : 612 - 620
  • [4] NEUROENDOCRINE EFFECTS OF IPSAPIRONE ON THE HYPOTHALAMIC-PITUITARY ADRENAL AXIS - CRF, ACTH AND CORTISOL IN HEALTHY-VOLUNTEERS
    BENEKE, M
    WINGENDER, W
    HORSTMANN, R
    KONRADDALHOFF, I
    WEBER, H
    KUHLMANN, J
    SCHMIDT, BH
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (02) : 163 - 169
  • [5] Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners
    Broocks, A
    Meyer, T
    George, A
    Hillmer-Vogel, U
    Meyer, D
    Bandelow, B
    Hajak, G
    Bartmann, U
    Gleiter, CH
    Rüther, E
    [J]. NEUROPSYCHOPHARMACOLOGY, 1999, 20 (02) : 150 - 161
  • [6] PROLACTIN AND STRESS - SOME ENDOCRINE CORRELATES OF PREOPERATIVE ANXIETY
    BROOKS, JE
    HERBERT, M
    WALDER, CP
    SELBY, C
    JEFFCOATE, WJ
    [J]. CLINICAL ENDOCRINOLOGY, 1986, 24 (06) : 653 - 656
  • [7] Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects
    Cleare, AJ
    Murray, RM
    OKeane, V
    [J]. NEUROPSYCHOPHARMACOLOGY, 1996, 14 (05) : 349 - 354
  • [8] Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects
    Cleare, AJ
    Bond, AJ
    [J]. PSYCHIATRY RESEARCH, 1997, 69 (2-3) : 89 - 95
  • [9] CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573
  • [10] CLONINGER CR, 1988, PSYCHIATRIC DEV, V2, P83